Odyssey Evaluation in Post LASIK Patients

Inclusion criteria

Subjects MUST fulfill the following conditions to qualify for enrollment into the trial

• Age: 50 years and older.
• Gender: Males and Females.
• Bilateral cataracts
• Bilateral implantation of Odyssey IOLs (toric and non-toric)
• Scheduled to undergo standard cataract surgery in both eyes, within 1 to 30 days between surgeries.
• Willing and able to provide written informed consent for participation in the study.
• Willing and able to comply with scheduled visits and study examination procedures.
• Postoperative best corrected visual acuity of 0.2 logMAR (20/32 Snellen) or better in each eye.

Exclusion criteria

Subjects with ANY of the following conditions on the eligibility exam may NOT be enrolled into the trial.

• Established ocular pathology, including: glaucoma (except glaucoma suspects), uveitis, and clinically-significant retinal pathology affecting the macula (with visual acuity worse than 20/25) and/or any other ocular findings that may, in the opinion of the investigator, affect vision.
• Uncontrolled diabetes.
• Use of any systemic or topical drug known to interfere with visual performance.
• Any concurrent infectious/non-infectious conjunctivitis, keratitis or uveitis.
• Clinically significant corneal dystrophy.
• Contact lens use during the active treatment portion of the trial.
• Irregular astigmatism.
• Corneal irregularities potentially affecting visual acuity (i.e., keratoconus, corneal opacities
• History of chronic intraocular inflammation.
• History of retinal detachment.
• Pseudoexfoliation syndrome or any other condition that has the potential to weaken the zonules.
• Previous intraocular surgery.
• Previous keratoplasty
• Previous refractive surgery other than myopic LASIK or PRK (i.e., radial keratotomy, hyperopic LASIK, etc)
• Severe dry eye.
• Pupil abnormalities.
• Subject who may reasonably be expected to require a secondary surgical intervention at any time during the study (other than YAG capsulotomy, i.e., LASIK).
• Any clinically significant, serious, or severe medical or psychiatric condition that may interfere with the interpretation of study results.
• Participation in (or current participation) any ophthalmic investigational drug or ophthalmic device trial within the previous 30 days prior to the start date of this trial.
• Inability to focus or fixate for prolonged periods of time (e.g., due to strabismus, nystagmus, etc.)
• Abnormal iris

The principal investigator reserves the right to declare a patient ineligible or non-evaluable based on medical evidence that indicates the patient is unsuitable for the trial.